Trading Radar for 8/15: Sysco (SYY), 500.com (WBAI), Famous Dave's (DAVE), Cinedigm (CIDM) Report
- Nasdaq, S&P tumble as Netflix, chip stocks drag; AmEx boosts Dow
- Sony/Apollo bid for Paramount could be worth as much as $29 billion - Source
- Netflix Q1 earnings top estimates on blowout subscriber growth
- Nasdaq tumbles, Treasuries dip amid earnings, geopolitical crosscurrents
- Gold prices rally past $2,400 on reports of Israel strikes on Iran
- Tritium DCFC Limited (DCFC): Three Australian subsidiaries were determined to be insolvent or likely to become insolvent
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- Jabil falls after placing CEO on paid leave amid internal investigation
- Frontier Communications (FYBR) says third party had gained unauthorized access to portions of its information technology environment
- Ibotta (IBTA) Prices 6.56M Share IPO at $88/sh
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
- Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
- After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
Credit Suisse Raises Price Target on Alarm.com Holdings, Inc. (ALRM) as Hardware Drives 2Q Beat
August 16, 2016 10:17 AM EDTCredit Suisse reiterated an Outperform rating on Alarm.com Holdings, Inc. (NASDAQ: ALRM), and raised the price target to $35.00 (from $28.00), following the company's 2Q earnings report. ALRM reported results all above estimates, with Hardware revenue driving the company's top line beat.
Analyst Michael Nemeroff commented, "ALRM posted strong Q2 results, in our view, with revenue, adj. EBITDA, and EPS all above expectations. Hardware... More
Needham & Company Raises Price Target on Fabrinet (FN) Following 4Q
August 16, 2016 9:02 AM EDTNeedham & Company reiterated a Buy rating on Fabrinet (NYSE: FN), and raised the price target to $54.00 (from $48.00), following the company's 4Q earnings report. Overall revenues came in at $276MM, up 37%. Guidance calls for $306-310MM, with $22MM from extra week as the September quarter has 14... More
FBR Capital Reiterates Outperform on Evoke Pharma (EVOK) Following 2Q Report
August 16, 2016 8:42 AM EDTFBR Capital reiterated an Outperform rating and $9.00 price target on Evoke Pharma (NASDAQ: EVOK) following the company's 2Q earnings report. EVOK reported a 2Q16 net loss of $3.0 million, or ($0.41)/ share, versus estimates of a net loss of $3.4 million, or ($0.47)/share.
Analyst Vernon Bernardino commented, "On... More